Your browser doesn't support javascript.
loading
Temporal improvements noted in life expectancy of patients with colorectal cancer; a Dutch population-based study.
Qaderi, Seyed M; Andersson, Therese M L; Dickman, Paul W; de Wilt, Johannes H W; Verhoeven, Rob H A.
Afiliação
  • Qaderi SM; Department of Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands. Electronic address: seyed.qaderi@radboudumc.nl.
  • Andersson TML; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Dickman PW; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • de Wilt JHW; Department of Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands.
  • Verhoeven RHA; Department of Surgical Oncology, Radboud university medical center, Nijmegen, The Netherlands; Department of Research and Development, Comprehensive Netherlands Cancer Organization, Utrecht, The Netherlands.
J Clin Epidemiol ; 137: 92-103, 2021 09.
Article em En | MEDLINE | ID: mdl-33836257
ABSTRACT

OBJECTIVE:

Specific survival estimates are needed for the increasing number of colorectal cancer (CRC) survivors. The aim of this population-based study was to determine conditional loss in expectation of life (LEL) due to CRC. STUDY DESIGN AND

SETTING:

All surgically treated patients with CRC registered in the Netherlands Cancer Registry with stage I-III between 1990-2016, were included (N = 203,216). Estimates of conditional LEL were predicted using flexible parametric models and the total life years lost due to cancer were estimated.

RESULTS:

LEL decreased with older age and patients with rectal cancer or higher disease stage had highest LEL. In 2010, LEL for sixty-year old male and female patients was 2 vs. 2, 4 vs. 4, and 7 vs. 8 years for colon cancer, and 2 vs. 2, 4 vs. 5 and 7 vs. 8 years for rectal cancer, respectively. Conditional LEL in patients with CRC decreased during follow-up. Patients with combined stage I-III colon and rectal cancer in 2010 lost an estimated 18,628 and 11,336 life years.

CONCLUSION:

This study quantified the impact of CRC on patient's life expectancy, both on individual and population level and demonstrated temporal improvements in CRC survival. These results provide meaningful information that can be used during follow-up.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Expectativa de Vida Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Clin Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Expectativa de Vida Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Clin Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2021 Tipo de documento: Article